The European Union and the United States have completed the assessment of all EU Member States' competent authorities under the pharmaceutical Good Manufacturing Practice (GMP) Mutual Recognition Agreement (MRA) for veterinary products. As of 29 May 2026, the agreement's veterinary provisions are fully operational, enabling regulators to rely on each other's GMP inspection results and removing the need for routine duplicate inspections of manufacturing sites covered by the agreement. EU-US veterinary GMP mutual recognition: from scope extension to full implementation Veterinary products were added to the EU–US MRA Sectoral Annex on...